Original news and analysis on international IP policy
By Tove Iren S. Gerhardsen There may be a market advantage for small and medium-sized pharmaceutical enterprises (SMEs) in focusing on diseases prevalent in developing countries that are neglected by larger companies, according to a recent seminar. The seminar was…
Par Tove Iren S. Gerhardsen À Washington, un haut fonctionnaire américain de la santé publique invite instamment le président de l’Organisation mondiale de la santé à retirer une publication commanditée par l’OMS qui se montre critique envers la politique commerciale…
[Editor’s Note: This story was modified shortly after publication to reflect the WHO reply on meeting participation.] By Tove Iren S. Gerhardsen The World Health Organization (WHO) has set the dates for online consultations on the working group on public…
By Tove Iren S. Gerhardsen A meeting of the World Trade Organization committee responsible for intellectual property rights this week erupted in disagreement over how to address enforcement of those rights in the committee. The debate in the 25-26 October…
By Tove Iren S. Gerhardsen Participants at a recent United Nations seminar on developing country production of essential medicines agreed that such a scenario should be possible but they disagreed on the means to get there. While there was disagreement…
By Tove Iren S. Gerhardsen The European Union has received support from Japan, Switzerland and the United States in its push to raise enforcement of intellectual property rights higher on the agenda of the World Trade Organization (WTO). On the…
By Tove Iren S. Gerhardsen As part of its greater focus on accountability and transparency, the global pharmaceutical industry will launch a new code of marketing ethics next year, it announced at its recent biennial meeting in Geneva. Meanwhile, its…
By Tove Iren S. Gerhardsen Following the rejection of a patent application for one of its medicines, Swiss pharmaceutical company Novartis has taken the “unprecedented action” of challenging India’s patent law in a high court, arguing that it is unconstitutional…
By Tove Iren S. Gerhardsen The European Parliament yesterday agreed by a large majority to the European Commission’s plan of going forward with talks on patent reform in Europe, but with a number of amendments to the current plan aimed…
Por William New El 3 de octubre, las asambleas anuales de la Organización Mundial de la Propiedad Intelectual (OMPI) concluyeron con un raro espíritu de cooperación y algunos recordatorios forzados sobre la difícil labor normativa y administrativa que deberá realizarse…
By Tove Iren S. Gerhardsen [Editor’s Note, 12 October: Parliament passed the resolution, with amendments, according to informed sources. Details to follow soon.] Members of the European Parliament will vote on 12 October on a resolution that would give the…
New Negotiators In Geneva: European Commission Expert on GIs, Indian Official on Biodiversity. Also, The World's Top 50 IP People, new names at WIPO and the NGOs, and more. In the IP-Watch People News.